NRX Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
/ 
Frequently asked questions
To buy NRX Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NRX Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NRX Pharmaceuticals Inc. is NRXP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NRX Pharmaceuticals Inc. has its primary listing on NASDAQ (Small cap). You can trade NRX Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NRX Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include NRX Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like NRX Pharmaceuticals Inc..